Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
By the end of 2022, the global automated cell biology systems market is anticipated to be worth US$ 14.1 Billion, and it will grow at a CAGR of 9.0% to reach an expected valuation of around US$ 33.5 Billion by the year 2032. Infinite cell line cultures dominate the worldwide market in 2021, with a share of around 76.2%, according to a recent analysis by Future Market Insights.
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2022 | US$ 14.1 Billion |
Market Value 2032 | US$ 33.5 Billion |
CAGR 2022 to 2032 | 9.0% |
Market Share of Top 5 Countries | 62.3% |
Key Market Players | Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza, Sartorius AG, Hitachi. Ltd, Nanoentek, ChemoMetec, Danaher Corporation, Agilent Technologies, Perkin Elmer (Nexcelom Bioscience LLC.), F. Hoffmann-La Roche AG, SHIMADZU CORPORATION, Bio-Rad Laboratories, Miltenyi Biotec, Sinfonia Technology, SHIBUYA CORPORATION, Advanced Instruments, Cell Culture Company, LLC, BD, and Hamilton Company |
Compared to the widespread methods utilized in the second half of the twentieth century, modern cell cultivation techniques are not significantly different. Despite the fact that these techniques made it possible to comprehend a variety of biological processes and that they served as determining factors for applications like drug testing and tissue regeneration, they had a number of inherent drawbacks. In actuality, conventional cell culture systems necessitate numerous and intricate manual handling techniques, which restricts the consistency of the cultivation in terms of cell yield and activity.
Additionally, long-term cell maintenance is costly, time-consuming, and demands a lot of reagents, test samples, and work. By reducing the number of operator interventions, the shift to user-friendly automated devices would favor standardizing the cultivation process, cutting production costs, and shortening the time required for cell culture preparation, thus promoting market growth for automated cell biology systems.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for automated cell biology systems was approximately 65.8% of the overall ~US$ 19.9 Billion global bioprocess technology market in 2021.
The sale of automated cell biology systems expanded at a CAGR of 6.6% from 2015 to 2021.
Technologies like microfluidics and lab-on-a-chip represent a strategic approach to support the shift to user-friendly automated equipment. By using microculture systems in place of conventional Petri plates and flasks for cellular tests, researchers have been able to minimize the number of reagents used while still achieving high-throughput cell generation and culture in a controlled setting.
The development of tissue engineering aims to increase the possibility of replacing tissue development for regenerating or restoring organ and tissue function. Tissue engineering technology has advanced significantly in recent years, and it is now widely used in domains other than medicine, such as organs-on-a-chip, bioelectronic devices, cultured meats, and so on.
Cell culture is the primary method used for tissue engineering manufacturing. Therefore, it is crucial for tissue engineering research to maintain high standards for cell culture settings.
Modern uses of analytical system automation include clinical, pharmacological, and biomedical environments. The automatic system has played a significant role in both qualitative and quantitative analysis. Optically driven, electrochemical, and mass spectroscopic approaches have all been used as analytical techniques. Robotic automation lowers the cost of analysis while providing high precision and high system throughput.
Numerous lab-on-chip advancements have been made for cell culture and certain other biomedical applications. A cell culture device indicates the viability of the cells, nutrient consumption, nutrient output in the fermentation process, and pharmacological effect.
Because of the aforementioned factors, it is anticipated that from 2022 to 2032, the global automated cell biology systems market will expand at a CAGR of 9.0%.
As automated cell culture, on-chip is widely acknowledged as a benchmark parameter in existing microfluidic systems for cell biology, and a plethora of studies have been documented in the literature. At the research laboratory level, the minimization and downsizing of additional peripheral equipment are considered a fundamental necessity for the utilization of automated devices in cell culture, coupled with the need for systems that are ready-to-use in a plug-and-play mode.
Currently, the use of micro-devices for fluidic control is limited to the use of relatively complicated, specialized, and bulky external equipment and macro-to-micro interface systems, necessitating the ongoing assistance of human operators to manage fluid flow in an unstandardized and manual manner.
The systematic application of a suitably integrated control system for accurate fluid handling in a remote control framework will significantly improve the usability and readout dependability of micro-bioreactors. This is crucial in automating cell culture techniques, reducing human involvement, and significantly lowering the number of connection tubes, intake and output ports, and bulky external equipment.
The adoption of such control systems is gaining traction, owing to the above-mentioned factors, and this is set to pose lucrative opportunities for growth within the global automated cell biology systems market during the forecasted years.
Cell-based therapies have the ability to provide a successful treatment for medical disorders that are presently incurable. Their widespread commercialization has been put at risk by constraints such as scaling up and automating labor-intensive research discoveries, high production costs, and batch variance in large-scale automated manufacturing.
Additionally, even though many cell culture labs employ automated tools to do away with manual duties like handling plates, highly-trained lab staff are still required to spend hours every day maintaining these devices. As a result, the majority of benchtop automation has limitations in terms of scaling in cell culture facilities.
Furthermore, the utilization of mammalian cell culture is quickly expanding. Even though the fundamental processes for sustaining cells are quite repeatable, the majority of cell culture operations are still done by hand.
Personnel is required to perform repetitive tasks for hours on end each day, and frequently they must come in after regular working hours to cater to the cells or modify their biology to accommodate the workload. Both the workflow's throughput and its ability to be tracked are limited by this dependence on manual steps.
With the above-mentioned factors, the market for automated cell biology systems experiences a restraint in growth.
With a market share of 89.8% in all of North America in 2021, the USA presently dominates the region and is expected to sustain this growth throughout the forecast period.
The increasing expenditure on Research and Development in the area can be attributed to the market's expansion. Additionally, the expansion of pharmaceutical firms and manufacturers in the area together with rising public awareness of stem cell therapy is anticipated to significantly contribute to the market's expansion. Additionally, it is predicted that the rising number of bone marrow and cord blood transplants across the region will favorably influence market growth.
China represents roughly 64.9% of the East Asia market in 2021, with growth at a lucrative CAGR of 13.7% throughout the forecast period. China has a significant demand for automation, according to the International Federation of Robotics (IFR). According to sales volume, China was one of the top five markets for industrial robots in 2015.
The China Robot Industry Alliance estimates that Chinese robot suppliers sold about 20,400 units in 2015, increasing their share of the global market from 25% to 29% from 2013 until 2015. With the growing wave in automation, as well as its adoption, China is posed to be a highly lucrative market for automated cell biology systems over the forecast period.
During the forecast years, Germany is projected to grow at a CAGR of nearly 7.2% in the global automated cell biology systems market. The European Medicinal Agency (EMA) granted the CliniMACS Prodigy platform approval for the commercial manufacturing process in 2018 for the customization of protocols, which is accomplished through modularity and flexible programming, allowing its use for a number of different cell types, including the development of CAR-T cells, macrophages, virus-specific T-cells, and dendritic cells. With the manufacturing of such capable platforms, Germany is set to aid with the growth of the overall market during the projected period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Automated cell counters (single function) are the leading segment as a product, hold approximately 34.6% market share in 2021, and are expected to present high growth at a CAGR of 8.1% throughout the forecast period. The benefit of using an automated cell counter is that it largely eliminates human bias from the cell counting process. They can count more cells and are frequently faster than manually counting, which improves statistical accuracy. Automated cell counters are also employed in research and clinical labs. They can be used on urine and blood samples to count the different cell types present or to evaluate the viability of a cultivated cell line for investigation.
Infinite cell line cultures hold a global market share of around 76.2%, in 2021. Infinite cell line cultures are more robust and convenient to work with than primary cells since they can reproduce indefinitely. Infinite cell line cultures are also convenient for researchers because they are less expensive, easier to use, and able to survive more stages than primary cells. Because cell lines have a limitless supply of material and are simple to alter and grow, they are preferred for multiple screenings.
Drug development holds a share of around 35.4% in 2021, and this segment is expected to display gradual growth over the forecast period. New scientific developments in basic research, drug development, drug discovery, and customized medicine applications are being driven by 3D cell cultures. To understand the full potential of the technology, researchers can operate more efficiently with complex reagents and precious cells with the aid of high throughput, automated liquid handling solutions.
Biopharmaceutical companies hold the highest market share value of 27.4% during the year 2021. Growing drug development activities propelled by the rising demand for personalized medicine will propel this segment in terms of growth during the projected years. With the standardization of laboratory protocols, as well as the utilization of automated systems for process control technologies during the production process, this segment gains a higher share among the rest of the end users within the global market.
Key players in the market present novel solutions for the lab automation processes for cell biology systems. Moreover, with increasing approvals from the regulatory authorities for software-based total lab automation systems, the key players are presented with an opportunistic outlook for growth during the forecast period.
Similarly, recent developments related to companies manufacturing automated cell biology systems have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2032 |
Historical Data Available for | 2015 to 2021 |
Market Analysis | US$ Billion for Value |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa |
Key Market Segments Covered | Product, Cell Culture, Application, End User, and Region |
Key Companies Profiled |
|
Pricing | Available upon Request |
The global automated cell biology systems market stands at US$ 14.1 Billion in 2022 and is set to expand 2.4X over the next ten years.
The automated cell biology systems market is expected to reach US$ 33.5 Billion by end of 2032 at a CAGR of 9.0%.
The growing geriatric population, the rising burden of chronic and infectious diseases, and rising Research and Development on novel biopharmaceuticals are some of the key trends in this market.
By region, North America holds the highest market share of around 37.4% by value, in 2021, in the global automated cell biology systems market.
Europe is projected to grow with a CAGR of 7.5% during the forecast period.
The USA, Germany, India, China, and the United Kingdom are the top five countries, which are expected to drive demand in the automated cell biology systems market.
Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza, Sartorius AG, Hitachi. Ltd, Nanoentek, ChemoMetec, Danaher Corporation, Agilent Technologies, Perkin Elmer (Nexcelom Bioscience LLC.), F. Hoffmann-La Roche AG, SHIMADZU CORPORATION, Bio-Rad Laboratories, Miltenyi Biotec, Sinfonia Technology, SHIBUYA CORPORATION, Advanced Instruments, Cell Culture Company, LLC, BD, and Hamilton Company, are some of the key players in the automated cell biology systems industry.
From 2015 to 2021, the market for automated cell biology systems expanded at the rate of 6.6% CAGR.
The automated cell biology systems market in South Asia is expected to grow at 12.3% CAGR during the forecast period.
East Asia is set to present lucrative growth at a CAGR of 13.1% during the forecasted years.
The automated cell biology systems market in South Asia is expected to grow at 12.3% CAGR during the forecast period.
East Asia is set to present lucrative growth at a CAGR of 13.1% during the forecasted years.
1. Executive Summary | Automated Cell Biology Systems Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption Analysis 4.2. Regulatory Landscape 4.3. Reimbursement Scenario 4.4. PESTEL Analysis 4.5. Porter’s Analysis 4.6. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Outlook 5.1.3. Global Market Overview 5.2. Forecast Factors - Relevance & Impact 5.2.1. Increasing Prevalence of Chronic and Infectious Diseases 5.2.2. Growing Elderly Population 5.2.3. Growing Efforts on Stem Cell Research 5.2.4. Increasing Demand for Gene Therapies 5.2.5. Rising Biopharmaceutical Production 5.2.6. Growing Investments in R&D 5.2.7. Rising Adoption of Automated Systems for Bulk Manufacturing 5.2.8. Increasing Focus on New Drug Discovery and Development 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. By Product 6.1.2. By Application 6.1.3. By Cell Culture 6.1.4. By End User 6.1.5. By Country 6.2. 2021 Market Scenario 7. Global Market Volume (Units) Analysis 2015 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Volume (Units) Analysis, 2015 to 2021 7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product 8.2. Pricing Break-up 8.2.1. Manufacturer-Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Market Demand (in Value or Size in US$ Million) Analysis 2015 to 2021 and Forecast, 2022 to 2032 9.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021 9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2015 to 2021 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2022 to 2032 10.3.1. Cell Culture Process Automatization Instrument or Robot (Multiple Function) 10.3.2. Automated Bioreactor (Single or Multiple Function) 10.3.3. Automated Cell Culture Media Exchange System (Single Function) 10.3.4. Automated Culture Media Analyzer (Single Function) 10.3.5. Automated Cell Wash-and-Concentrate System (Single Function) 10.3.6. Automated Cell Counter (Single Function) 10.3.7. Automated Fill and Finish System (Single Function) 10.3.8. Automated Cell Storage Equipment (Single Function) 10.3.9. Management Software 10.4. Market Attractiveness Analysis By Product 11. Global Market Analysis, By Cell Culture 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Cell Culture, 2015 to 2021 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Cell Culture, 2022 to 2032 11.3.1. Finite Cell Line Cultures 11.3.2. Infinite Cell Line Cultures 11.4. Market Attractiveness Analysis By Cell Culture 12. Global Market Analysis, By Application 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis, By Application, 2015 to 2021 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2032 12.3.1. Cell Therapy 12.3.2. Drug Development 12.3.3. Stem Cell Research 12.3.4. Regenerative Medicine 12.4. Market Attractiveness Analysis By Application 13. Global Market Analysis, By End User 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Million) Analysis, By End User, 2015 to 2021 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032 13.3.1. Mega Pharmaceutical companies 13.3.2. Biopharmaceutical companies 13.3.3. CDMOs/CMOs 13.3.4. Research organizations 13.3.5. Academic institutes 13.4. Market Attractiveness Analysis By End User 14. Global Market Analysis, By Region 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2015 to 2021 14.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032 14.3.1. North America 14.3.2. Latin America 14.3.3. Europe 14.3.4. East Asia 14.3.5. South Asia 14.3.6. Oceania 14.3.7. Middle East and Africa (MEA) 14.4. Market Attractiveness Analysis By Region 15. North America Market Analysis 15.1. Introduction 15.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 15.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032 15.3.1. By Country 15.3.1.1. USA 15.3.1.2. Canada 15.3.2. By Product 15.3.3. By Application 15.3.4. By Cell Culture 15.3.5. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Cell Culture 15.4.4. By Application 15.4.5. By End User 15.5. Market Trends 15.6. Drivers and Restraints - Impact Analysis 15.7. Country-Level Analysis & Forecast 15.7.1. USA Market Analysis 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Product 15.7.1.2.2. By Cell Culture 15.7.1.2.3. By Application 15.7.1.2.4. By End User 15.7.2. Canada Market Analysis 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Product 15.7.2.2.2. By Cell Culture 15.7.2.2.3. By Application 15.7.2.2.4. By End User 16. Latin America Market Analysis 16.1. Introduction 16.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 16.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032 16.3.1. By Country 16.3.1.1. Mexico 16.3.1.2. Brazil 16.3.1.3. Argentina 16.3.1.4. Rest of Latin America 16.3.2. By Product 16.3.3. By Cell Culture 16.3.4. By Application 16.3.5. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Cell Culture 16.4.4. By Application 16.4.5. By End User 16.5. Market Trends 16.6. Drivers and Restraints - Impact Analysis 16.7. Country-Level Analysis & Forecast 16.7.1. Mexico Market Analysis 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Product 16.7.1.2.2. By Cell Culture 16.7.1.2.3. By Application 16.7.1.2.4. By End User 16.7.2. Brazil Market Analysis 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Product 16.7.2.2.2. By Cell Culture 16.7.2.2.3. By Application 16.7.2.2.4. By End User 16.7.3. Argentina Market Analysis 16.7.3.1. Introduction 16.7.3.2. Market Analysis and Forecast by Market Taxonomy 16.7.3.2.1. By Product 16.7.3.2.2. By Cell Culture 16.7.3.2.3. By Application 16.7.3.2.4. By End User 17. Europe Market Analysis 17.1. Introduction 17.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 17.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032 17.3.1. By Country 17.3.1.1. Germany 17.3.1.2. Italy 17.3.1.3. France 17.3.1.4. United Kingdom 17.3.1.5. Spain 17.3.1.6. BENELUX 17.3.1.7. Russia 17.3.1.8. Rest of Europe 17.3.2. By Product 17.3.3. By Cell Culture 17.3.4. By Application 17.3.5. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Cell Culture 17.4.4. By Application 17.4.5. By End User 17.5. Market Trends 17.6. Drivers and Restraints - Impact Analysis 17.7. Country-Level Analysis & Forecast 17.7.1. Germany Market Analysis 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast by Market Taxonomy 17.7.1.2.1. By Product 17.7.1.2.2. By Cell Culture 17.7.1.2.3. By Application 17.7.1.2.4. By End User 17.7.2. Italy Market Analysis 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast by Market Taxonomy 17.7.2.2.1. By Product 17.7.2.2.2. By Cell Culture 17.7.2.2.3. By Application 17.7.2.2.4. By End User 17.7.3. France Market Analysis 17.7.3.1. Introduction 17.7.3.2. Market Analysis and Forecast by Market Taxonomy 17.7.3.2.1. By Product 17.7.3.2.2. By Cell Culture 17.7.3.2.3. By Application 17.7.3.2.4. By End User 17.7.4. United Kingdom Market Analysis 17.7.4.1. Introduction 17.7.4.2. Market Analysis and Forecast by Market Taxonomy 17.7.4.2.1. By Product 17.7.4.2.2. By Cell Culture 17.7.4.2.3. By Application 17.7.4.2.4. By End User 17.7.5. Spain Market Analysis 17.7.5.1. Introduction 17.7.5.2. Market Analysis and Forecast by Market Taxonomy 17.7.5.2.1. By Product 17.7.5.2.2. By Cell Culture 17.7.5.2.3. By Application 17.7.5.2.4. By End User 17.7.6. BENELUX Market Analysis 17.7.6.1. Introduction 17.7.6.2. Market Analysis and Forecast by Market Taxonomy 17.7.6.2.1. By Product 17.7.6.2.2. By Cell Culture 17.7.6.2.3. By Application 17.7.6.2.4. By End User 17.7.7. Russia Market Analysis 17.7.7.1. Introduction 17.7.7.2. Market Analysis and Forecast by Market Taxonomy 17.7.7.2.1. By Product 17.7.7.2.2. By Cell Culture 17.7.7.2.3. By Application 17.7.7.2.4. By End User 18. East Asia Market Analysis 18.1. Introduction 18.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 18.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Product 18.3.3. By Cell Culture 18.3.4. By Application 18.3.5. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Cell Culture 18.4.3. By Product 18.4.4. By Application 18.4.5. By End User 18.5. Market Trends 18.6. Drivers and Restraints - Impact Analysis 18.7. Country-Level Analysis & Forecast 18.7.1. China Market Analysis 18.7.1.1. Introduction 18.7.1.2. Market Analysis and Forecast by Market Taxonomy 18.7.1.2.1. By Product 18.7.1.2.2. By Cell Culture 18.7.1.2.3. By Application 18.7.1.2.4. By End User 18.7.2. Japan Market Analysis 18.7.2.1. Introduction 18.7.2.2. Market Analysis and Forecast by Market Taxonomy 18.7.2.2.1. By Product 18.7.2.2.2. By Cell Culture 18.7.2.2.3. By Application 18.7.2.2.4. By End User 18.7.3. South Korea Market Analysis 18.7.3.1. Introduction 18.7.3.2. Market Analysis and Forecast by Market Taxonomy 18.7.3.2.1. By Product 18.7.3.2.2. By Cell Culture 18.7.3.2.3. By Application 18.7.3.2.4. By End User 19. South Asia Market Analysis 19.1. Introduction 19.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 19.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032 19.3.1. By Country 19.3.1.1. India 19.3.1.2. Indonesia 19.3.1.3. Malaysia 19.3.1.4. Thailand 19.3.1.5. Rest of South Asia 19.3.2. By Product 19.3.3. By Cell Culture 19.3.4. By Application 19.3.5. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Cell Culture 19.4.3. By Product 19.4.4. By Application 19.4.5. By End User 19.5. Market Trends 19.6. Drivers and Restraints - Impact Analysis 19.7. Country-Level Analysis & Forecast 19.7.1. India Market Analysis 19.7.1.1. Introduction 19.7.1.2. Market Analysis and Forecast by Market Taxonomy 19.7.1.2.1. By Product 19.7.1.2.2. By Cell Culture 19.7.1.2.3. By Application 19.7.1.2.4. By End User 19.7.2. Indonesia Market Analysis 19.7.2.1. Introduction 19.7.2.2. Market Analysis and Forecast by Market Taxonomy 19.7.2.2.1. By Product 19.7.2.2.2. By Cell Culture 19.7.2.2.3. By Application 19.7.2.2.4. By End User 19.7.3. Malaysia Market Analysis 19.7.3.1. Introduction 19.7.3.2. Market Analysis and Forecast by Market Taxonomy 19.7.3.2.1. By Product 19.7.3.2.2. By Cell Culture 19.7.3.2.3. By Application 19.7.3.2.4. By End User 19.7.4. Thailand Market Analysis 19.7.4.1. Introduction 19.7.4.2. Market Analysis and Forecast by Market Taxonomy 19.7.4.2.1. By Product 19.7.4.2.2. By Cell Culture 19.7.4.2.3. By Application 19.7.4.2.4. By End User 20. Oceania Market Analysis 20.1. Introduction 20.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 20.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032 20.3.1. By Country 20.3.1.1. Australia 20.3.1.2. New Zealand 20.3.2. By Product 20.3.3. By Cell Culture 20.3.4. By Application 20.3.5. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Cell Culture 20.4.4. By Application 20.4.5. By End User 20.5. Key Market Participants - Intensity Mapping 20.6. Drivers and Restraints - Impact Analysis 20.7. Country-Level Analysis & Forecast 20.7.1. Australia Market Analysis 20.7.1.1. Introduction 20.7.1.2. Market Analysis and Forecast by Market Taxonomy 20.7.1.2.1. By Product 20.7.1.2.2. By Cell Culture 20.7.1.2.3. By Application 20.7.1.2.4. By End User 20.7.2. New Zealand Market Analysis 20.7.2.1. Introduction 20.7.2.2. Market Analysis and Forecast by Market Taxonomy 20.7.2.2.1. By Product 20.7.2.2.2. By Cell Culture 20.7.2.2.3. By Application 20.7.2.2.4. By End User 21. Middle East and Africa (MEA) Market Analysis 21.1. Introduction 21.2. Historical Market Size (US$ Million) Trend and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021 21.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast, 2022 to 2032 21.3.1. By Country 21.3.1.1. GCC Countries 21.3.1.2. Turkey 21.3.1.3. North Africa 21.3.1.4. South Africa 21.3.1.5. Rest of Middle East and Africa 21.3.2. By Product 21.3.3. By Cell Culture 21.3.4. By Application 21.3.5. By End User 21.4. Market Attractiveness Analysis 21.4.1. By Country 21.4.2. By Product 21.4.3. By Cell Culture 21.4.4. By Application 21.4.5. By End User 21.5. Market Trends 21.6. Drivers and Restraints - Impact Analysis 21.7. Country-Level Analysis & Forecast 21.7.1. GCC Countries Market Analysis 21.7.1.1. Introduction 21.7.1.2. Market Analysis and Forecast by Market Taxonomy 21.7.1.2.1. By Product 21.7.1.2.2. By Cell Culture 21.7.1.2.3. By Application 21.7.1.2.4. By End User 21.7.2. Turkey Market Analysis 21.7.2.1. Introduction 21.7.2.2. Market Analysis and Forecast by Market Taxonomy 21.7.2.2.1. By Product 21.7.2.2.2. By Cell Culture 21.7.2.2.3. By Application 21.7.2.2.4. By End User 21.7.3. South Africa Market Analysis 21.7.3.1. Introduction 21.7.3.2. Market Analysis and Forecast by Market Taxonomy 21.7.3.2.1. By Product 21.7.3.2.2. By Cell Culture 21.7.3.2.3. By Application 21.7.3.2.4. By End User 21.7.4. North Africa Market Analysis 21.7.4.1. Introduction 21.7.4.2. Market Analysis and Forecast by Market Taxonomy 21.7.4.2.1. By Product 21.7.4.2.2. By Cell Culture 21.7.4.2.3. By Application 21.7.4.2.4. By End User 22. Market Structure Analysis 22.1. Market Analysis by Tier of Companies 22.2. Market Share Analysis of Top Players 22.3. Market Presence Analysis 23. Competition Analysis 23.1. Competition Dashboard 23.2. Competition Benchmarking 23.3. Competition Deep Dive 23.3.1. Thermo Fisher Scientific 23.3.1.1. Overview 23.3.1.2. Product Portfolio 23.3.1.3. Sales Footprint 23.3.1.4. Key Financials 23.3.1.5. SWOT Analysis 23.3.1.6. Strategy Overview 23.3.1.6.1. Marketing Strategy 23.3.1.6.2. Product Strategy 23.3.1.6.3. Channel Strategy 23.3.2. Corning Incorporated 23.3.2.1. Overview 23.3.2.2. Product Portfolio 23.3.2.3. Sales Footprint 23.3.2.4. Key Financials 23.3.2.5. SWOT Analysis 23.3.2.6. Strategy Overview 23.3.2.6.1. Marketing Strategy 23.3.2.6.2. Product Strategy 23.3.2.6.3. Channel Strategy 23.3.3. Merck KGaA 23.3.3.1. Overview 23.3.3.2. Product Portfolio 23.3.3.3. Sales Footprint 23.3.3.4. Key Financials 23.3.3.5. SWOT Analysis 23.3.3.6. Strategy Overview 23.3.3.6.1. Marketing Strategy 23.3.3.6.2. Product Strategy 23.3.3.6.3. Channel Strategy 23.3.4. Lonza 23.3.4.1. Overview 23.3.4.2. Product Portfolio 23.3.4.3. Sales Footprint 23.3.4.4. Key Financials 23.3.4.5. SWOT Analysis 23.3.4.6. Strategy Overview 23.3.4.6.1. Marketing Strategy 23.3.4.6.2. Product Strategy 23.3.4.6.3. Channel Strategy 23.3.5. Sartorius AG 23.3.5.1. Overview 23.3.5.2. Product Portfolio 23.3.5.3. Sales Footprint 23.3.5.4. Key Financials 23.3.5.5. SWOT Analysis 23.3.5.6. Strategy Overview 23.3.5.6.1. Marketing Strategy 23.3.5.6.2. Product Strategy 23.3.5.6.3. Channel Strategy 23.3.6. Hitachi. Ltd 23.3.6.1. Overview 23.3.6.2. Product Portfolio 23.3.6.3. Sales Footprint 23.3.6.4. Key Financials 23.3.6.5. SWOT Analysis 23.3.6.6. Strategy Overview 23.3.6.6.1. Marketing Strategy 23.3.6.6.2. Product Strategy 23.3.6.6.3. Channel Strategy 23.3.7. Nanoentek 23.3.7.1. Overview 23.3.7.2. Product Portfolio 23.3.7.3. Sales Footprint 23.3.7.4. Key Financials 23.3.7.5. SWOT Analysis 23.3.7.6. Strategy Overview 23.3.7.6.1. Marketing Strategy 23.3.7.6.2. Product Strategy 23.3.7.6.3. Channel Strategy 23.3.8. ChemoMetec 23.3.8.1. Overview 23.3.8.2. Product Portfolio 23.3.8.3. Sales Footprint 23.3.8.4. Key Financials 23.3.8.5. SWOT Analysis 23.3.8.6. Strategy Overview 23.3.8.6.1. Marketing Strategy 23.3.8.6.2. Product Strategy 23.3.8.6.3. Channel Strategy 23.3.9. Danaher corporation 23.3.9.1. Overview 23.3.9.2. Product Portfolio 23.3.9.3. Sales Footprint 23.3.9.4. Key Financials 23.3.9.5. SWOT Analysis 23.3.9.6. Strategy Overview 23.3.9.6.1. Marketing Strategy 23.3.9.6.2. Product Strategy 23.3.9.6.3. Channel Strategy 23.3.10. Agilent Technologies 23.3.10.1. Overview 23.3.10.2. Product Portfolio 23.3.10.3. Sales Footprint 23.3.10.4. Key Financials 23.3.10.5. SWOT Analysis 23.3.10.6. Strategy Overview 23.3.10.6.1. Marketing Strategy 23.3.10.6.2. Product Strategy 23.3.10.6.3. Channel Strategy 23.3.11. Perkin Elmer (Nexcelom Bioscience LLC.) 23.3.11.1. Overview 23.3.11.2. Product Portfolio 23.3.11.3. Sales Footprint 23.3.11.4. Key Financials 23.3.11.5. SWOT Analysis 23.3.11.6. Strategy Overview 23.3.11.6.1. Marketing Strategy 23.3.11.6.2. Product Strategy 23.3.11.6.3. Channel Strategy 23.3.12. F. Hoffmann-La Roche AG 23.3.12.1. Overview 23.3.12.2. Product Portfolio 23.3.12.3. Sales Footprint 23.3.12.4. Key Financials 23.3.12.5. SWOT Analysis 23.3.12.6. Strategy Overview 23.3.12.6.1. Marketing Strategy 23.3.12.6.2. Product Strategy 23.3.12.6.3. Channel Strategy 23.3.13. SHIMADZU CORPORATION 23.3.13.1. Overview 23.3.13.2. Product Portfolio 23.3.13.3. Sales Footprint 23.3.13.4. Key Financials 23.3.13.5. SWOT Analysis 23.3.13.6. Strategy Overview 23.3.13.6.1. Marketing Strategy 23.3.13.6.2. Product Strategy 23.3.13.6.3. Channel Strategy 23.3.14. Bio-Rad Laboratories 23.3.14.1. Overview 23.3.14.2. Product Portfolio 23.3.14.3. Sales Footprint 23.3.14.4. Key Financials 23.3.14.5. SWOT Analysis 23.3.14.6. Strategy Overview 23.3.14.6.1. Marketing Strategy 23.3.14.6.2. Product Strategy 23.3.14.6.3. Channel Strategy 23.3.15. Miltenyi Biotec 23.3.15.1. Overview 23.3.15.2. Product Portfolio 23.3.15.3. Sales Footprint 23.3.15.4. Key Financials 23.3.15.5. SWOT Analysis 23.3.15.6. Strategy Overview 23.3.15.6.1. Marketing Strategy 23.3.15.6.2. Product Strategy 23.3.15.6.3. Channel Strategy 23.3.16. Sinfonia Technology 23.3.16.1. Overview 23.3.16.2. Product Portfolio 23.3.16.3. Sales Footprint 23.3.16.4. Key Financials 23.3.16.5. SWOT Analysis 23.3.16.6. Strategy Overview 23.3.16.6.1. Marketing Strategy 23.3.16.6.2. Product Strategy 23.3.16.6.3. Channel Strategy 23.3.17. SHIBUYA CORPORATION 23.3.17.1. Overview 23.3.17.2. Product Portfolio 23.3.17.3. Sales Footprint 23.3.17.4. Key Financials 23.3.17.5. SWOT Analysis 23.3.17.6. Strategy Overview 23.3.17.6.1. Marketing Strategy 23.3.17.6.2. Product Strategy 23.3.17.6.3. Channel Strategy 23.3.18. Advanced Instruments 23.3.18.1. Overview 23.3.18.2. Product Portfolio 23.3.18.3. Sales Footprint 23.3.18.4. Key Financials 23.3.18.5. SWOT Analysis 23.3.18.6. Strategy Overview 23.3.18.6.1. Marketing Strategy 23.3.18.6.2. Product Strategy 23.3.18.6.3. Channel Strategy 23.3.19. Cell Culture Company, LLC 23.3.19.1. Overview 23.3.19.2. Product Portfolio 23.3.19.3. Sales Footprint 23.3.19.4. Key Financials 23.3.19.5. SWOT Analysis 23.3.19.6. Strategy Overview 23.3.19.6.1. Marketing Strategy 23.3.19.6.2. Product Strategy 23.3.19.6.3. Channel Strategy 23.3.20. BD 23.3.20.1. Overview 23.3.20.2. Product Portfolio 23.3.20.3. Sales Footprint 23.3.20.4. Key Financials 23.3.20.5. SWOT Analysis 23.3.20.6. Strategy Overview 23.3.20.6.1. Marketing Strategy 23.3.20.6.2. Product Strategy 23.3.20.6.3. Channel Strategy 23.3.21. Hamilton Company 23.3.21.1. Overview 23.3.21.2. Product Portfolio 23.3.21.3. Sales Footprint 23.3.21.4. Key Financials 23.3.21.5. SWOT Analysis 23.3.21.6. Strategy Overview 23.3.21.6.1. Marketing Strategy 23.3.21.6.2. Product Strategy 23.3.21.6.3. Channel Strategy 24. Assumptions and Acronyms Used 25. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 01: Global Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product Table 02: Global Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product Table 03: Global Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture Table 04: Global Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application Table 05: Global Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User Table 06: North America Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country Table 07: North America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product Table 08: North America Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product Table 09: North America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture Table 10: North America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application Table 11: North America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User Table 12: Latin America Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country Table 13: Latin America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product Table 14: Latin America Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product Table 15: Latin America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture Table 16: Latin America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application Table 17: Latin America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User Table 18: Europe Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country Table 19: Europe Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product Table 20: Europe Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product Table 21: Europe Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture Table 22: Europe Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application Table 23: Europe Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User Table 24: South Asia Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country Table 25: South Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product Table 26: South Asia Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product Table 27: South Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture Table 28: South Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application Table 29: South Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User Table 30: East Asia Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country Table 31: East Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product Table 32: East Asia Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product Table 33: East Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture Table 34: East Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application Table 35: East Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User Table 36: Oceania Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country Table 37: Oceania Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product Table 38: Oceania Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product Table 39: Oceania Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture Table 40: Oceania Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application Table 41: Oceania Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User Table 42: MEA Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country Table 43: MEA Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product Table 44: MEA Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product Table 45: MEA Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture Table 46: MEA Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application Table 47: MEA Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User
Figure 01: Global Market Volume (Units), 2015 – 2021 Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, Figure 03: Automated Cell Biology Systems, Pricing Analysis per unit (US$), in 2022 Figure 04: Automated Cell Biology Systems, Pricing Forecast per unit (US$), in 2032 Figure 05: Global Market Value (US$ Million) Analysis, 2015 to 2021 Figure 06: Global Market Forecast & Y-o-Y Growth, 2022 to 2032 Figure 07: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2021–2032 Figure 08: Global Market Value Share (%) Analysis 2022 and 2032, by Product Figure 09: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Product Figure 10: Global Market Attractiveness Analysis 2022 to 2032, by Product Figure 11: Global Market Value Share (%) Analysis 2022 and 2032, by Cell Culture Figure 12: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Cell Culture Figure 13: Global Market Attractiveness Analysis 2022 to 2032, by Cell Culture Figure 14: Global Market Value Share (%) Analysis 2022 and 2032, by Application Figure 15: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Application Figure 16: Global Market Attractiveness Analysis 2022 to 2032, by Application Figure 17: Global Market Value Share (%) Analysis 2022 and 2032, by End User Figure 18: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by End User Figure 19: Global Market Attractiveness Analysis 2022 to 2032, by End User Figure 20: Global Market Value Share (%) Analysis 2022 and 2032, by Region Figure 21: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Region Figure 22: Global Market Attractiveness Analysis 2022 to 2032, by Region Figure 23: North America Market Value (US$ Million) Analysis, 2015 to 2021 Figure 24: North America Market Value (US$ Million) Forecast, 2022 to 2032 Figure 25: North America Market Value Share, by Product (2022 E) Figure 26: North America Market Value Share, by Cell Culture (2022 E) Figure 27: North America Market Value Share, by Application (2022 E) Figure 28: North America Market Value Share, by End User (2022 E) Figure 29: North America Market Value Share, by Country (2022 E) Figure 30: North America Market Attractiveness Analysis by Product, 2022 to 2032 Figure 31: North America Market Attractiveness Analysis by Cell Culture, 2022 to 2032 Figure 32: North America Market Attractiveness Analysis by Application, 2022 to 2032 Figure 33: North America Market Attractiveness Analysis by End User, 2022 to 2032 Figure 34: North America Market Attractiveness Analysis by Country, 2022 to 2032 Figure 35: U.S. Market Value Proportion Analysis, 2021 Figure 36: Global Vs. U.S. Growth Comparison Figure 37: U.S. Market Share Analysis (%) by Product, 2021 & 2032 Figure 38: U.S. Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 39: U.S. Market Share Analysis (%) by Application, 2021 & 2032 Figure 40: U.S. Market Share Analysis (%) by End User, 2021 & 2032 Figure 41: Canada Market Value Proportion Analysis, 2021 Figure 42: Global Vs. Canada. Growth Comparison Figure 43: Canada Market Share Analysis (%) by Product, 2021 & 2032 Figure 44: Canada Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 45: Canada Market Share Analysis (%) by Application, 2021 & 2032 Figure 46: Canada Market Share Analysis (%) by End User, 2021 & 2032 Figure 47: Latin America Market Value (US$ Million) Analysis, 2015 to 2021 Figure 48: Latin America Market Value (US$ Million) Forecast, 2022 to 2032 Figure 49: Latin America Market Value Share, by Product (2022 E) Figure 50: Latin America Market Value Share, by Cell Culture (2022 E) Figure 51: Latin America Market Value Share, by Application (2022 E) Figure 52: Latin America Market Value Share, by End User (2022 E) Figure 53: Latin America Market Value Share, by Country (2022 E) Figure 54: Latin America Market Attractiveness Analysis by Product, 2022 to 2032 Figure 55: Latin America Market Attractiveness Analysis by Cell Culture, 2022 to 2032 Figure 56: Latin America Market Attractiveness Analysis by Application, 2022 to 2032 Figure 57: Latin America Market Attractiveness Analysis by End User, 2022 to 2032 Figure 58: Latin America Market Attractiveness Analysis by Country, 2022 to 2032 Figure 59: Mexico Market Value Proportion Analysis, 2021 Figure 60: Global Vs Mexico Growth Comparison Figure 61: Mexico Market Share Analysis (%) by Product, 2021 & 2032 Figure 62: Mexico Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 63: Mexico Market Share Analysis (%) by Application, 2021 & 2032 Figure 64: Mexico Market Share Analysis (%) by End User, 2021 & 2032 Figure 65: Brazil Market Value Proportion Analysis, 2021 Figure 66: Global Vs. Brazil. Growth Comparison Figure 67: Brazil Market Share Analysis (%) by Product, 2021 & 2032 Figure 68: Brazil Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 69: Brazil Market Share Analysis (%) by Application, 2021 & 2032 Figure 70: Brazil Market Share Analysis (%) by End User, 2021 & 2032 Figure 71: Argentina Market Value Proportion Analysis, 2021 Figure 72: Global Vs Argentina Growth Comparison Figure 73: Argentina Market Share Analysis (%) by Product, 2021 & 2032 Figure 74: Argentina Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 75: Argentina Market Share Analysis (%) by Application, 2021 & 2032 Figure 76: Argentina Market Share Analysis (%) by End User, 2021 & 2032 Figure 77: Europe Market Value (US$ Million) Analysis, 2015 to 2021 Figure 78: Europe Market Value (US$ Million) Forecast, 2022 to 2032 Figure 79: Europe Market Value Share, by Product (2022 E) Figure 80: Europe Market Value Share, by Cell Culture (2022 E) Figure 81: Europe Market Value Share, by Application (2022 E) Figure 82: Europe Market Value Share, by End User (2022 E) Figure 83: Europe Market Value Share, by Country (2022 E) Figure 84: Europe Market Attractiveness Analysis by Product, 2022 to 2032 Figure 85: Europe Market Attractiveness Analysis by Cell Culture, 2022 to 2032 Figure 86: Europe Market Attractiveness Analysis by Application, 2022 to 2032 Figure 87: Europe Market Attractiveness Analysis by End User, 2022 to 2032 Figure 88: Europe Market Attractiveness Analysis by Country, 2022 to 2032 Figure 89: UK Market Value Proportion Analysis, 2021 Figure 90: Global Vs. UK Growth Comparison Figure 91: UK Market Share Analysis (%) by Product, 2021 & 2032 Figure 92: UK Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 93: UK Market Share Analysis (%) by Application, 2021 & 2032 Figure 94: UK Market Share Analysis (%) by End User, 2021 & 2032 Figure 95: Germany Market Value Proportion Analysis, 2021 Figure 96: Global Vs. Germany Growth Comparison Figure 97: Germany Market Share Analysis (%) by Product, 2021 & 2032 Figure 98: Germany Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 99: Germany Market Share Analysis (%) by Application, 2021 & 2032 Figure 100: Germany Market Share Analysis (%) by End User, 2021 & 2032 Figure 101: Italy Market Value Proportion Analysis, 2021 Figure 102: Global Vs. Italy Growth Comparison Figure 103: Italy Market Share Analysis (%) by Product, 2021 & 2032 Figure 104: Italy Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 105: Italy Market Share Analysis (%) by Application, 2021 & 2032 Figure 106: Italy Market Share Analysis (%) by End User, 2021 & 2032 Figure 107: France Market Value Proportion Analysis, 2021 Figure 108: Global Vs France Growth Comparison Figure 109: France Market Share Analysis (%) by Product, 2021 & 2032 Figure 110: France Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 111: France Market Share Analysis (%) by Application, 2021 & 2032 Figure 112: France Market Share Analysis (%) by End User, 2021 & 2032 Figure 113: Spain Market Value Proportion Analysis, 2021 Figure 114: Global Vs Spain Growth Comparison Figure 115: Spain Market Share Analysis (%) by Product, 2021 & 2032 Figure 116: Spain Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 117: Spain Market Share Analysis (%) by Application, 2021 & 2032 Figure 118: Spain Market Share Analysis (%) by End User, 2021 & 2032 Figure 119: Russia Market Value Proportion Analysis, 2021 Figure 120: Global Vs Russia Growth Comparison Figure 121: Russia Market Share Analysis (%) by Product, 2021 & 2032 Figure 122: Russia Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 123: Russia Market Share Analysis (%) by Application, 2021 & 2032 Figure 124: Russia Market Share Analysis (%) by End User, 2021 & 2032 Figure 125: BENELUX Market Value Proportion Analysis, 2021 Figure 126: Global Vs BENELUX Growth Comparison Figure 127: BENELUX Market Share Analysis (%) by Product, 2021 & 2032 Figure 128: BENELUX Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 129: BENELUX Market Share Analysis (%) by Application, 2021 & 2032 Figure 130: BENELUX Market Share Analysis (%) by End User, 2021 & 2032 Figure 131: East Asia Market Value (US$ Million) Analysis, 2015 to 2021 Figure 132: East Asia Market Value (US$ Million) Forecast, 2022 to 2032 Figure 133: East Asia Market Value Share, by Product (2022 E) Figure 134: East Asia Market Value Share, by Cell Culture (2022 E) Figure 135: East Asia Market Value Share, by Application (2022 E) Figure 136: East Asia Market Value Share, by End User (2022 E) Figure 137: East Asia Market Value Share, by Country (2022 E) Figure 138: East Asia Market Attractiveness Analysis by Product, 2022 to 2032 Figure 139: East Asia Market Attractiveness Analysis by Cell Culture, 2022 to 2032 Figure 140: East Asia Market Attractiveness Analysis by Application, 2022 to 2032 Figure 141: East Asia Market Attractiveness Analysis by End User, 2022 to 2032 Figure 142: East Asia Market Attractiveness Analysis by Country, 2022 to 2032 Figure 143: China Market Value Proportion Analysis, 2021 Figure 144: Global Vs. China Growth Comparison Figure 145: China Market Share Analysis (%) by Product, 2021 & 2032 Figure 146: China Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 147: China Market Share Analysis (%) by Application, 2021 & 2032 Figure 148: China Market Share Analysis (%) by End User, 2021 & 2032 Figure 149: Japan Market Value Proportion Analysis, 2021 Figure 150: Global Vs. Japan Growth Comparison Figure 151: Japan Market Share Analysis (%) by Product, 2021 & 2032 Figure 152: Japan Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 153: Japan Market Share Analysis (%) by Application, 2021 & 2032 Figure 154: Japan Market Share Analysis (%) by End User, 2021 & 2032 Figure 155: South Korea Market Value Proportion Analysis, 2021 Figure 156: Global Vs South Korea Growth Comparison Figure 157: South Korea Market Share Analysis (%) by Product, 2021 & 2032 Figure 158: South Korea Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 159: South Korea Market Share Analysis (%) by Application, 2021 & 2032 Figure 160: South Korea Market Share Analysis (%) by End User, 2021 & 2032 Figure 161: South Asia Market Value (US$ Million) Analysis, 2015 to 2021 Figure 162: South Asia Market Value (US$ Million) Forecast, 2022 to 2032 Figure 163: South Asia Market Value Share, by Product (2022 E) Figure 164: South Asia Market Value Share, by Cell Culture (2022 E) Figure 165: South Asia Market Value Share, by Application (2022 E) Figure 166: South Asia Market Value Share, by End User (2022 E) Figure 167: South Asia Market Value Share, by Country (2022 E) Figure 168: South Asia Market Attractiveness Analysis by Product, 2022 to 2032 Figure 169: South Asia Market Attractiveness Analysis by Cell Culture, 2022 to 2032 Figure 170: South Asia Market Attractiveness Analysis by Application, 2022 to 2032 Figure 171: South Asia Market Attractiveness Analysis by End User, 2022 to 2032 Figure 172: South Asia Market Attractiveness Analysis by Country, 2022 to 2032 Figure 173: India Market Value Proportion Analysis, 2021 Figure 174: Global Vs. India Growth Comparison Figure 175: India Market Share Analysis (%) by Product, 2021 & 2032 Figure 176: India Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 177: India Market Share Analysis (%) by Application, 2021 & 2032 Figure 178: India Market Share Analysis (%) by End User, 2021 & 2032 Figure 179: Indonesia Market Value Proportion Analysis, 2021 Figure 180: Global Vs. Indonesia Growth Comparison Figure 181: Indonesia Market Share Analysis (%) by Product, 2021 & 2032 Figure 182: Indonesia Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 183: Indonesia Market Share Analysis (%) by Application, 2021 & 2032 Figure 184: Indonesia Market Share Analysis (%) by End User, 2021 & 2032 Figure 185: Malaysia Market Value Proportion Analysis, 2021 Figure 186: Global Vs. Malaysia Growth Comparison Figure 187: Malaysia Market Share Analysis (%) by Product, 2021 & 2032 Figure 188: Malaysia Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 189: Malaysia Market Share Analysis (%) by Application, 2021 & 2032 Figure 190: Malaysia Market Share Analysis (%) by End User, 2021 & 2032 Figure 191: Thailand Market Value Proportion Analysis, 2021 Figure 192: Global Vs. Thailand Growth Comparison Figure 193: Thailand Market Share Analysis (%) by Product, 2021 & 2032 Figure 194: Thailand Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 195: Thailand Market Share Analysis (%) by Application, 2021 & 2032 Figure 196: Thailand Market Share Analysis (%) by End User, 2021 & 2032 Figure 197: Oceania Market Value (US$ Million) Analysis, 2015 to 2021 Figure 198: Oceania Market Value (US$ Million) Forecast, 2022 to 2032 Figure 199: Oceania Market Value Share, by Product (2022 E) Figure 200: Oceania Market Value Share, by Cell Culture (2022 E) Figure 201: Oceania Market Value Share, by Application (2022 E) Figure 202: Oceania Market Value Share, by End User (2022 E) Figure 203: Oceania Market Value Share, by Country (2022 E) Figure 204: Oceania Market Attractiveness Analysis by Product, 2022 to 2032 Figure 205: Oceania Market Attractiveness Analysis by Cell Culture, 2022 to 2032 Figure 206: Oceania Market Attractiveness Analysis by Application, 2022 to 2032 Figure 207: Oceania Market Attractiveness Analysis by End User, 2022 to 2032 Figure 208: Oceania Market Attractiveness Analysis by Country, 2022 to 2032 Figure 209: Australia Market Value Proportion Analysis, 2021 Figure 210: Global Vs. Australia Growth Comparison Figure 211: Australia Market Share Analysis (%) by Product, 2021 & 2032 Figure 212: Australia Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 213: Australia Market Share Analysis (%) by Application, 2021 & 2032 Figure 214: Australia Market Share Analysis (%) by End User, 2021 & 2032 Figure 215: New Zealand Market Value Proportion Analysis, 2021 Figure 216: Global Vs New Zealand Growth Comparison Figure 217: New Zealand Market Share Analysis (%) by Product, 2021 & 2032 Figure 218: New Zealand Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 219: New Zealand Market Share Analysis (%) by Application, 2021 & 2032 Figure 220: New Zealand Market Share Analysis (%) by End User, 2021 & 2032 Figure 221: Middle East & Africa Market Value (US$ Million) Analysis, 2015 to 2021 Figure 222: Middle East & Africa Market Value (US$ Million) Forecast, 2022 to 2032 Figure 223: Middle East & Africa Market Value Share, by Product (2022 E) Figure 224: Middle East & Africa Market Value Share, by Cell Culture (2022 E) Figure 225: Middle East & Africa Market Value Share, by Application (2022 E) Figure 226: Middle East & Africa Market Value Share, by End User (2022 E) Figure 227: Middle East & Africa Market Value Share, by Country (2022 E) Figure 228: Middle East & Africa Market Attractiveness Analysis by Product, 2022 to 2032 Figure 229: Middle East & Africa Market Attractiveness Analysis by Cell Culture, 2022 to 2032 Figure 230: Middle East & Africa Market Attractiveness Analysis by Application, 2022 to 2032 Figure 231: Middle East & Africa Market Attractiveness Analysis by End User, 2022 to 2032 Figure 232: Middle East & Africa Market Attractiveness Analysis by Country, 2022 to 2032 Figure 233: GCC Countries Market Value Proportion Analysis, 2021 Figure 234: Global Vs GCC Countries Growth Comparison Figure 235: GCC Countries Market Share Analysis (%) by Product, 2021 & 2032 Figure 236: GCC Countries Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 237: GCC Countries Market Share Analysis (%) by Application, 2021 & 2032 Figure 238: GCC Countries Market Share Analysis (%) by End User, 2021 & 2032 Figure 239: Turkey Market Value Proportion Analysis, 2021 Figure 240: Global Vs. Turkey Growth Comparison Figure 241: Turkey Market Share Analysis (%) by Product, 2021 & 2032 Figure 242: Turkey Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 243: Turkey Market Share Analysis (%) by Application, 2021 & 2032 Figure 244: Turkey Market Share Analysis (%) by End User, 2021 & 2032 Figure 245: South Africa Market Value Proportion Analysis, 2021 Figure 246: Global Vs. South Africa Growth Comparison Figure 247: South Africa Market Share Analysis (%) by Product, 2021 & 2032 Figure 248: South Africa Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 249: South Africa Market Share Analysis (%) by Application, 2021 & 2032 Figure 250: South Africa Market Share Analysis (%) by End User, 2021 & 2032 Figure 251: North Africa Market Value Proportion Analysis, 2021 Figure 252: Global Vs North Africa Growth Comparison Figure 253: North Africa Market Share Analysis (%) by Product, 2021 & 2032 Figure 254: North Africa Market Share Analysis (%) by Cell Culture, 2021 & 2032 Figure 255: North Africa Market Share Analysis (%) by Application, 2021 & 2032 Figure 256: North Africa Market Share Analysis (%) by End User, 2021 & 2032
Recommendations
Explore Healthcare Insights
View Reports